GERMAN PATIENT ROUNDTABLE – Cenedella.de

"Giving voice to the needs of the German Medical Marijuana/Cannabis Patient Community" / Cenedella, Patient Advocate since 1977.

Medical Cannabis & Cannabinoids EU: Where Do We Go From Here? –15th to 16th November 2018 – Frankfurt, Germany

Leave a comment

0001181_medical-cannabis-cannabinoids-eu-where-do-we-go-from-here_200

Join us this November 15th & 16th and be part of medical cannabis

& cannabinoids EU where do we go from here?
15% Discount Code LM15SPK

The only medical cannabis conference created to answer the serious questions behind all things cannabis and cannabinoid in the EU.

Forums and Events cordially invite you to participate in the most exciting topic to hit the medical and business industry in the past 20+ years!

Since the onset of legalization of medical cannabis in Germany, there are still many unknowns concerning the impact it will have on the scientific & medical implications for patients. Secondary to this are the issues surrounding the clarity of laws and legislation concerning everything from licensing, to regulations for both producers and end users. There is intense global interest in business opportunities from both an investment and development side as well. These are just a few of the bigger topics being explored. More importantly and possibly the biggest question of them all is:

 

Where do we go from here?  
Join us this November 15th & 16th in Frankfurt Am Main for a thought provoking and proactive oriented conference.  This is an invaluable opportunity for the diversified members of the cannabis industry to come together and network, learn about the trade and get answers!

We will explore the medical implications of cannabis products for patient treatment in areas such as cancer, epilepsy, glaucoma, HIV/AIDS, post-traumatic stress disorder (PTSD), amyotrophic lateral sclerosis (ALS), Crohn’s disease, Parkinson’s disease, as well as multiple sclerosis. The list just keeps getting longer.

Lecturers from the scientific community will discuss and present their latest cannabinoid research and development findings.

The conference will also concentrate on business development, investment opportunities, and collaborative projects to shed light on how it will all impact the European market as a whole.

 

We thank you in advance for your patronage. Please share this information with anyone you think would benefit.

 

Sincerely,

The Forums and Events Team

 

Author: Cenedella.de

Philip J. Cenedella IV Over the last 4 decades I have been involved in the fight for patient rights in America, and now here in Germany. I have served as a Board of Director for the World Trade Center San Diego, as a Lead Consultant for Deutsche Telekom's Executive Board, Founded the Dayton Human Trafficking Accords and have been a C-Level Business Development Executive in the technology sector. Since 2016 I have been fulltime in the legal medical marijuana industry, helping companies navigate the biggest potential market in the world. This website is light on details due to confidentiality issues, but be rest assured I am knowledgeable and can assist your growth in some way. Consulting Services: Sales and Business Development Assist with Strategic Direction Professionally represent your firm Licensing and compliance Sales and Distribution networks Qualify potential partners I am your resource, on the ground in Europe! Philip J. Cenedella IV Call +1.888.206.3264 USA +49.0.151.720.17652 GERMANY Skype: philip.j.cenedella eMail: phil@cenedella.de LinkedIN: https://www.linkedin.com/in/cenedellade/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.